Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland · Delayed Price · Currency is PLN 73.20
+0.40 (0.55%)
Aug 20, 2026, 5:00 PM CET
WSE:CTX Market Cap
WSE:CTX has a market cap or net worth of 465.07 million as of August 20, 2026. Its market cap has increased by 108.73% in one year.
Market Cap
465.07M
Enterprise Value
450.37M
Revenue
2.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
73.20
ChartMarket Cap Chart
Since April 19, 2021, WSE:CTX's market cap has decreased from 749.17M to 465.07M, a decrease of -37.92%. That is a compound annual growth rate of -8.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 465.07M | 16.83% |
| Dec 30, 2025 | 398.07M | 101.82% |
| Dec 30, 2024 | 197.24M | -57.12% |
| Dec 29, 2023 | 459.93M | -31.04% |
| Dec 30, 2022 | 666.90M | -10.15% |
| Dec 30, 2021 | 742.21M | -0.93% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 546.44M |
| Bioceltix | 449.22M |
| Ryvu Therapeutics | 429.11M |
| BIOTON | 327.14M |
| Synthaverse | 217.84M |
| Poltreg | 151.46M |
| Molecure | 126.92M |
| Mabion | 123.48M |